» Articles » PMID: 38836151

Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature

Overview
Journal Cureus
Date 2024 Jun 5
PMID 38836151
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotics are among the most common causes of drug-induced liver injury worldwide. Amoxicillin/clavulanic acid and nitrofurantoin are the most common culprits while tetracyclines are a rare cause of liver injury. Among tetracyclines, minocycline has been reported more frequently than doxycycline, which is an extremely rare cause of drug-induced liver injury. We present a healthy 28-year-old male patient from rural United States who was taking doxycycline for Lyme disease. After five days of therapy, he developed nausea, vomiting, fatigue, and significant transaminitis consistent with a hepatocellular pattern of liver injury. After a thorough workup which ruled out other causes such as infection, autoimmune diseases, liver malignancy, and vascular, structural, and metabolic disorders, his liver injury was attributed to doxycycline. We reached the diagnosis also by demonstrating a consistent temporal association between doxycycline intake and liver injury and the patient recovered completely with the cessation of doxycycline. Recognition of doxycycline as a cause of drug-induced liver injury should be considered in patients utilizing this antibiotic. Doxycycline, unlike minocycline, has a short latency period. Early recognition and discontinuation of doxycycline in our patient resulted in the complete resolution of symptoms and transaminitis preventing further morbidity and mortality.

References
1.
Alqahtani S, Kleiner D, Ghabril M, Gu J, Hoofnagle J, Rockey D . Identification and Characterization of Cefazolin-Induced Liver Injury. Clin Gastroenterol Hepatol. 2014; 13(7):1328-1336.e2. PMC: 4472636. DOI: 10.1016/j.cgh.2014.11.036. View

2.
Lucena M, Andrade R, Fernandez M, Pachkoria K, Pelaez G, Duran J . Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology. 2006; 44(4):850-6. DOI: 10.1002/hep.21324. View

3.
Fu L, Qian Y, Shang Z, Sun X, Kong X, Gao Y . Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis. Front Med (Lausanne). 2022; 9:972518. PMC: 9500153. DOI: 10.3389/fmed.2022.972518. View

4.
Bjornsson E, Kalaitzakis E, Olsson R . The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury. Aliment Pharmacol Ther. 2007; 25(12):1411-21. DOI: 10.1111/j.1365-2036.2007.03330.x. View

5.
Shi X, Lao D, Xu Q, Li X, Lv Q . A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infect Dis. 2022; 22(1):368. PMC: 9004110. DOI: 10.1186/s12879-022-07258-w. View